At a glance
ClinicalIndex Comparison RecordN/ACompleted· 46 enrolled
Drug / intervention
Green Tea Extract +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Gut-level Antiinflammatory Activities of Green Tea in Metabolic Syndrome
In Brief
A clinical study evaluating Green Tea Extract and Placebo for Dysbiosis and 3 related conditions. Completed, enrolled 46 participants across 1 site.
Detailed Summary
This study evaluates dietary green tea extract to improve gut health and inflammation in persons with metabolic syndrome and healthy adults. Participants will complete two phases of intervention in random order in which they will consume green tea extract or placebo for one month and then switch to the opposite treatment for an additional month.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDysbiosis, Endotoxemia, Metabolic Syndrome, Inflammation
CountriesUnited States
CollaboratorsUnited States Department of Agriculture (USDA)
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedJun 2019
Enrollment StartJul 2019
Primary CompletionMar 2021
TodayJul 2026
First PostedJun 4, 2019
Enrollment StartJul 1, 2019
Primary CompletionMar 1, 2021
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 7.1 years ago
Interventions
Green Tea Extractdietary
A gummy confection with catechin-rich green tea extract (1 g/d)
Placebodietary
A matched gummy confection formulated without green tea extract